Genetics Through a Primary Care Lens

Overview

Journal West J Med

Specialty General Medicine

Date 2001 Jun 30

PMID 11431403

Citations 2

Authors

L Pinsky

R Pagon

W Burke

Affiliations

Soon will be listed here.

Citing Articles

The importance of preventative medicine in conjunction with modern day genetic studies.

Sandler S, Alfino L, Saleem M Genes Dis. 2018; 5(2):107-111.

PMID: 30258938 PMC: 6146230. DOI: 10.1016/j.gendis.2018.04.002.

[Everything about my mother].

Cachafeiro S Aten Primaria. 2004; 34(1):61.

PMID: 15207206 PMC: 7688692. DOI: 10.1016/s0212-6567(04)79457-3.

References

Beutler E, Felitti V, Gelbart T, Ho N . The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Ann Intern Med. 2000; 133(5):329-37. DOI: 10.7326/0003-4819-133-5-200009050-00008. View

Campion D, Dumanchin C, Hannequin D, Dubois B, Belliard S, Puel M . Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet. 1999; 65(3):664-70. PMC: 1377972. DOI: 10.1086/302553. View

Marteau T, Lerman C . Genetic risk and behavioural change. BMJ. 2001; 322(7293):1056-9. PMC: 1120191. DOI: 10.1136/bmj.322.7293.1056. View

Pagon R, Hanson N, Covington M . Genetic testing. West J Med. 2001; 174(5):344-7. PMC: 1071396. DOI: 10.1136/ewjm.174.5.344. View

Burke W, Aitken M, Chen S, Scott C . Variable severity of pulmonary disease in adults with identical cystic fibrosis mutations. Chest. 1992; 102(2):506-9. DOI: 10.1378/chest.102.2.506. View

. Correlation between genotype and phenotype in patients with cystic fibrosis. N Engl J Med. 1993; 329(18):1308-13. DOI: 10.1056/NEJM199310283291804. View

Harris R, HARRIS H . Primary care for patients at genetic risk. BMJ. 1995; 311(7005):579-80. PMC: 2550654. DOI: 10.1136/bmj.311.7005.579. View

Burke W, Petersen G, Lynch P, Botkin J, Daly M, Garber J . Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. JAMA. 1997; 277(11):915-9. View

Burke W, Daly M, Garber J, Botkin J, Kahn M, Lynch P . Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA. 1997; 277(12):997-1003. View

10.

Struewing J, Hartge P, Wacholder S, Baker S, Berlin M, McAdams M . The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med. 1997; 336(20):1401-8. DOI: 10.1056/NEJM199705153362001. View

11.

Ford D, Easton D, Stratton M, Narod S, Goldgar D, Devilee P . Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1998; 62(3):676-89. PMC: 1376944. DOI: 10.1086/301749. View

12.

Marteau T, Croyle R . The new genetics. Psychological responses to genetic testing. BMJ. 1998; 316(7132):693-6. PMC: 1112686. DOI: 10.1136/bmj.316.7132.693. View

13.

Fodor F, Weston A, Bleiweiss I, McCurdy L, Walsh M, Tartter P . Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients. Am J Hum Genet. 1998; 63(1):45-51. PMC: 1377227. DOI: 10.1086/301903. View

14.

Thorlacius S, Struewing J, Hartge P, Olafsdottir G, Sigvaldason H, Tryggvadottir L . Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet. 1998; 352(9137):1337-9. DOI: 10.1016/s0140-6736(98)03300-5. View

15.

Welch H, Burke W . Uncertainties in genetic testing for chronic disease. JAMA. 1998; 280(17):1525-7. DOI: 10.1001/jama.280.17.1525. View

16.

Cogswell M, McDonnell S, Khoury M, Franks A, Burke W, Brittenham G . Iron overload, public health, and genetics: evaluating the evidence for hemochromatosis screening. Ann Intern Med. 1998; 129(11):971-9. DOI: 10.7326/0003-4819-129-11_part_2-199812011-00008. View

17.

Rosenthal T, Puck S . Screening for genetic risk of breast cancer. Am Fam Physician. 1999; 59(1):99-104, 106. View

18.

de Bock G, Vliet Vlieland T, Hageman G, Oosterwijk J, Springer M, Kievit J . The assessment of genetic risk of breast cancer: a set of GP guidelines. Fam Pract. 1999; 16(1):71-7. DOI: 10.1093/fampra/16.1.71. View

19.

Burke W, Press N, Pinsky L . BRCA1 and BRCA2: a small part of the puzzle. J Natl Cancer Inst. 1999; 91(11):904-5. DOI: 10.1093/jnci/91.11.904. View

20.

Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N . Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst. 1999; 91(11):943-9. DOI: 10.1093/jnci/91.11.943. View